>> Monday
>> Tuesday
>> Wednesday
Monday 30 June 2025
08:30 - 09:30
Invited session 01: Keynote session
Monday 30 June 2025
08:30 - 09:30: Invited session 01: Keynote session:
08:30 - 09:00
HR Keynote lecture
09:00 - 09:30
Detecting scientific fraud
Jennifer Byrne, Australia
09:00 - 12:00
Practicing embryo transfer techniques using a virtual reality-based simulator
09:00 - 12:00: Practicing embryo transfer techniques using a virtual reality-based simulator:
09:30 - 10:00
Coffee break
09:30 - 10:00: Coffee break:
10:00 - 11:30
6 Parallel Selected oral communications sessions
10:00 - 11:30: 6 Parallel Selected oral communications sessions:
10:00 - 11:30
Poster discussion session
10:00 - 11:30: Poster discussion session:
11:45 - 12:45
Invited session 02: Debate: Should we transfer embryos derived from 0PN-1PN-3PN?
11:45 - 12:45: Invited session 02: Debate: Should we transfer embryos derived from 0PN-1PN-3PN?:
Ioannis Sfontouris, Greece
Ioannis Sfontouris, Greece
11:45 - 12:45
Invited session 03: Data reporting session
11:45 - 12:45: Invited session 03: Data reporting session:
11:45 - 12:45
Invited session 04: ASRM Exchange session: Challenging cases: clinical and laboratory perspectives
11:45 - 12:45: Invited session 04: ASRM Exchange session: Challenging cases: clinical and laboratory perspectives:
Chairperson to be announced
11:45 - 12:00
Thin endometrium: cause for concern?
12:05 - 12:20
Contemporary approach to difficult cases in male reproduction
12:25 - 12:40
Importing cryopreserved gametes and embryos into the laboratory – know your limits!
11:45 - 12:45
Invited session 05: Managing weight and nurturing life
11:45 - 12:45: Invited session 05: Managing weight and nurturing life:
11:45 - 12:05
The impact of obesity on reproduction from menarche to menopause
Fionnuala M McAuliffe, Ireland
12:15 - 12:35
Obesity, implantation and early pregnancy - does GLP1 play a role?
David Westergaard, Denmark
11:45 - 12:45
Invited session 06: IRHEC session
11:45 - 12:45: Invited session 06: IRHEC session:
11:45 - 12:45
Poster discussion session
11:45 - 12:45: Poster discussion session:
13:00 - 14:00
Lunch break
13:00 - 14:00: Lunch break:
14:00 - 15:00
Invited session 07: Whole genome sequencing of human embryos: technical challanges and ethical dilemmas
14:00 - 15:00: Invited session 07: Whole genome sequencing of human embryos: technical challanges and ethical dilemmas:
14:00 - 14:20
Analytical capability and clinical utility of WGS in PGT
14:30 - 14:50
Ethical and counseling considerations
14:00 - 15:00
Invited session 08: Debate: IVF planning in poor prognosis patients - cycle to cycle approach or multicycle approach is best?
14:00 - 15:00: Invited session 08: Debate: IVF planning in poor prognosis patients - cycle to cycle approach or multicycle approach is best?:
14:00 - 14:15
Cycle to cycle approach is best!
14:15 - 14:30
Multicycle approach is a valid option in poor prognosis patients?
14:00 - 15:00
Invited session 09: FSANZ Exchange session
14:00 - 15:00: Invited session 09: FSANZ Exchange session:
14:00 - 14:20
Assessing the ploidy status of abnormally fertilised embryos – recovery of embryos for potential clinical use
14:00 - 15:00
Selected oral communications session
14:00 - 15:00: Selected oral communications session:
14:00 - 15:00
Invited session 10: Live journal club
14:00 - 15:00: Invited session 10: Live journal club:
14:00 - 15:00
Poster discussion session
14:00 - 15:00: Poster discussion session:
15:15 - 16:30
6 Parallel Selected oral communications sessions
15:15 - 16:30: 6 Parallel Selected oral communications sessions:
15:15 - 16:30
Poster discussion session
15:15 - 16:30: Poster discussion session:
16:30 - 17:00
Coffee break
16:30 - 17:00: Coffee break:
17:00 - 18:00
Invited session 11: Diagnostics/screening tests for endometriosis
17:00 - 18:00: Invited session 11: Diagnostics/screening tests for endometriosis:
17:00 - 17:20
Imaging for endometriosis: from the past to the future
Mee Kristine Aas-Eng, Norway
17:30 - 17:50
Beyond imaging: are we there yet?
17:00 - 18:00
Invited session 12: Male infertility and comorbidities - what do we know?
17:00 - 18:00: Invited session 12: Male infertility and comorbidities - what do we know?:
17:00 - 17:20
What we know from big cohort studies
Michael Eisenberg, U.S.A.
17:30 - 17:50
What we know of putative causal relations
17:00 - 18:00
Invited session 13: Innovations in vitro gametogenesis and gonadogenesis
17:00 - 18:00: Invited session 13: Innovations in vitro gametogenesis and gonadogenesis:
17:00 - 17:20
Pioneering in vitro gametogenesis
17:30 - 17:50
Pluripotent models for gonadal research
Anna Biason-Lauber, Switzerland
17:00 - 18:00
Selected oral communications
17:00 - 18:00: Selected oral communications:
17:00 - 18:00
Invited session 14: Guidelines session:Key updates on the ESHRE guidelines
17:00 - 18:00: Invited session 14: Guidelines session:Key updates on the ESHRE guidelines:
17:00 - 17:20
Fertility preservation in prepubertal males: 5 key
17:30 - 17:50
A revised ESHRE/ALPHA consensus on oocyte and embryo assessment: 5 essential takeaways
17:00 - 18:00
Poster discussion session
17:00 - 18:00: Poster discussion session: